ERK-dependent suicide gene therapy for selective targeting of RTK/RAS-driven cancers.

Day EK, Campbell A, Pandolf A, Rogerson T, Zhong Q, Xiao A, Purow B, Lazzara MJ
Mol Ther. 2021 Apr 7;29(4):1585-1601. doi: 10.1016/j.ymthe.2020.12.019. Epub 2020 Dec 15. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.